immunology

Trial in Britain to test the combination of Pfizer and AstraZeneca two-shot vaccines

Trial in Britain to test the combination of Pfizer and AstraZeneca two-shot vaccines

Patients recovered from COVID were likely to be protected for at least six months, according to the study

Patients recovered from COVID were likely to be protected for at least six months, according to the study

J&J joins COVID-19 vaccine armory with 66% efficiency in a global trial

The new variant COVID-19 defeats plasma treatment, may reduce the effectiveness of the vaccine

Explanator: COVID-19 vaccines increase confusion over China’s tests for travelers

Anti-nutrients are not as harmful as they seem

Progress has been reported on the one-dose J&J vaccine; COVID-19 reinfections are considered rare

Progress has been reported on the one-dose J&J vaccine; COVID-19 reinfections are considered rare